Topic: insulin producing cells
Vertex Pharmaceuticals is jumping into diabetes with a $950 million acquisition of Semma Therapeutics and its stem cell-based diabetes treatments.
Encellin is working on a cell pouch that cuts down on the scarring that comes with encapsulated cell transplants.
A UCSF team found that Type 1 diabetes starts with "secretory senescence," a process whereby DNA damage causes beta cells to stop working properly.
University of Geneva scientists showed how pancreatic cells that normally don't produce insulin can be converted to produce the hormone.
A team of Stanford University scientists has found a way to direct a regenerative diabetes medicine to the right cells more precisely.
Transplanting pancreatic islets, along with a hydrogel that "trains" immune cells to accept them, could translate to a cure for Type 1 diabetes.
Scientists in the U.S. and Japan devised a new tissue engineering method to tackle blood supply problems in pancreatic cell transplantation.
Lilly is diving into encapsulated beta cell treatments, designed to restore insulin production in patients with Type 1 diabetes.
Researchers confirmed that the pancreas contains stem cells that can become insulin-producing cells.
The week’s biotech discoveries include an insulin-related gene mutation and the news that previously ignored brain structures could govern obesity.